Publications by authors named "Isabel Rubio"

Claim this Profile
L
Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective.
Jean-Michel Hannoun-Levi, Julie Margenthaler, Bethany Anderson, Rosa Di Micco, Douglas Arthur, Isabel T Rubio

Eur J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.
André Pfob, Katja Pinker, Ines Vaz-Luis, Antonio Di Meglio, Maria João Cardoso, Isabel T Rubio

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.
Antonio J Esgueva, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Maria Joao Cardoso, Isabel T Rubio

J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally advanced breast cancers: the EUSOMA experience.
Peter van Dam, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Julie Verhaegen, Isabel T Rubio

Eur J Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance.
Giuseppe Catanuto, Damiano Gentile, Federica Martorana, Giuseppe Curigliano, Isabel Rubio

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).
Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, Nina Ditsch, Elmar Stickeler, Isabel T Rubio

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BJS commission on the surgical management of the axilla in breast cancer.
Michael R Boland, Oreste D Gentilini, G Bruce Mann, Jana de Boniface, Elena Leinert, Isabel T Rubio

Br J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.
Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, Elmar Stickeler, Michael Hauptmann, Isabel Teresa Rubio

Br J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.
Rosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, Jana de Boniface, Esther Schmidt, Isabel T Rubio

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database.
Giuseppe Catanuto, Damiano Gentile, Federica Martorana, Mariano Tomatis, Antonio Ponti, Isabel T Rubio

Eur J Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness of genomic testing among patients with breast cancer in Europe.
Antonella Cardone, Dany Bell, Conchi Biurrun, Francesco Cognetti, Fatima Cardoso, Isabel T Rubio

Breast· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer.
David Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, Elizabeth H Dibble, Gary A Ulaner, Isabel T Rubio

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients.
Ning Liao, Cheukfai Li, William J Gradishar, V Suzanne Klimberg, Joshua A Roshal, Isabel T Rubio

JCO Clin Cancer Inform· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR Bridges: image-guided breast cancer treatment de-escalation-a multidisciplinary view.
Ritse M Mann, Isabel T Rubio, C Willemien Menke-van der Houven van Oordt, Michael Fuchsjäger

Eur Radiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Maggie Banys-Paluchowski, Steffi Hartmann, Timo Basali, Maria Luisa Gasparri, Jana de Boniface, Isabel Rubio

Breast Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of [F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.
David Groheux, Sofia C Vaz, Philip Poortmans, Ritse M Mann, Gary A Ulaner, Isabel T Rubio

Breast· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-based breast cancer screening: What are the challenges?
Isabel T Rubio, Caroline A Drukker, Antonio Esgueva

Tumori· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.
Florentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, Giuseppe Viale, Suzette Delaloge, Isabel T Rubio

NPJ Breast Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
Carmela Caballero, Dara J Lundon, Mariela Vasileva-Slaveva, Giacomo Montagna, Eduard-Alexandru Bonci, Isabel T Rubio

Eur J Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two step procedures: sequels are never any good.
Christian Sisó, Isabel T Rubio

Gland Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint EANM-SNMMI guidelines on the role of 2-[F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines.
David Groheux, Sofia C Vaz, Gary A Ulaner, Gary J R Cook, John Patrick Pilkington Woll, Isabel T Rubio

Eur J Nucl Med Mol Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint EANM-SNMMI guideline on the role of 2-[F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Isabel T Rubio

Eur J Nucl Med Mol Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, Coralie Poncet, Ridwan O Olaniran, Isabel T Rubio

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292].
Isabel T Rubio, Lynda Wyld, Lorenza Marotti, Alexandra Athanasiou, Peter Regitnig

Eur J Surg Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EUSOMA quality indicators for non-metastatic breast cancer: An update.
Isabel T Rubio, Lorenza Marotti, Laura Biganzoli, Cynthia Aristei, Alexandra Athanasiou

Eur J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis